Tenchov R, Sasso J, Zhou Q
ACS Omega. 2025; 10(2):1864-1892.
PMID: 39866628
PMC: 11755173.
DOI: 10.1021/acsomega.4c09114.
Ho D, Kim H, Nam D, Seo M, Park S, Kim D
NeuroSci. 2024; 5(3):301-314.
PMID: 39483283
PMC: 11469749.
DOI: 10.3390/neurosci5030024.
Koshatwar M, Acharya S, Prasad R, Lohakare T, Wanjari M, Taksande A
Cureus. 2023; 15(9):e44763.
PMID: 37809189
PMC: 10556988.
DOI: 10.7759/cureus.44763.
Chandran A, Oliver H, Rochet J
Biology (Basel). 2023; 12(9).
PMID: 37759569
PMC: 10525699.
DOI: 10.3390/biology12091169.
Starr L, McKay L, Peter K, Seyfarth L, Berkowitz L, Caldwell K
J Dev Biol. 2023; 11(2).
PMID: 37218814
PMC: 10204437.
DOI: 10.3390/jdb11020020.
Neuronal Oxidative Stress Promotes α-Synuclein Aggregation In Vivo.
Won S, Fong R, Butler N, Sanchez J, Zhang Y, Wong C
Antioxidants (Basel). 2022; 11(12).
PMID: 36552674
PMC: 9774295.
DOI: 10.3390/antiox11122466.
The Role of the Thioredoxin System in Brain Diseases.
Bjorklund G, Zou L, Peana M, Chasapis C, Hangan T, Lu J
Antioxidants (Basel). 2022; 11(11).
PMID: 36358532
PMC: 9686621.
DOI: 10.3390/antiox11112161.
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
Ruz C, Barrero F, Pelegrina J, Bandres-Ciga S, Vives F, Duran R
Int J Mol Sci. 2022; 23(19).
PMID: 36233303
PMC: 9569857.
DOI: 10.3390/ijms231912004.
A novel LINC00943/miR-671-5p/ELAVL1 ceRNA crosstalk regulates MPP toxicity in SK-N-SH cells.
Zhang X, Luan N, Shi J
Metab Brain Dis. 2022; 37(7):2349-2362.
PMID: 35779150
DOI: 10.1007/s11011-022-01034-0.
Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders.
Balakrishnan R, Cho D, Kim I, Seol S, Choi D
Antioxidants (Basel). 2022; 11(2).
PMID: 35204164
PMC: 8868500.
DOI: 10.3390/antiox11020281.
Deubiquitinases in Neurodegeneration.
Bello A, Goswami R, Brown S, Costanzo K, Shores T, Allan S
Cells. 2022; 11(3).
PMID: 35159365
PMC: 8834042.
DOI: 10.3390/cells11030556.
Mitochondrial quality control in stroke: From the mechanisms to therapeutic potentials.
Tian H, Chen X, Liao J, Yang T, Cheng S, Mei Z
J Cell Mol Med. 2022; 26(4):1000-1012.
PMID: 35040556
PMC: 8831937.
DOI: 10.1111/jcmm.17189.
as a Model for Investigating Neurodegenerative Diseases.
Haver H, Scaglione K
Front Cell Neurosci. 2021; 15:759532.
PMID: 34776869
PMC: 8578527.
DOI: 10.3389/fncel.2021.759532.
Alpha-Synuclein Aggregation in Parkinson's Disease.
Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram A, Karunakaran R
Front Med (Lausanne). 2021; 8:736978.
PMID: 34733860
PMC: 8558257.
DOI: 10.3389/fmed.2021.736978.
Understanding the Potential of Genome Editing in Parkinson's Disease.
Arango D, Bittar A, Esmeral N, Ocasion C, Munoz-Camargo C, Cruz J
Int J Mol Sci. 2021; 22(17).
PMID: 34502143
PMC: 8430539.
DOI: 10.3390/ijms22179241.
A conserved ubiquitin- and ESCRT-dependent pathway internalizes human lysosomal membrane proteins for degradation.
Zhang W, Yang X, Chen L, Liu Y, Venkatarangan V, Reist L
PLoS Biol. 2021; 19(7):e3001361.
PMID: 34297722
PMC: 8337054.
DOI: 10.1371/journal.pbio.3001361.
MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson's Disease.
Zhang L, Chen X, Chang M, Jiao B
Front Cell Neurosci. 2021; 15:644507.
PMID: 34113238
PMC: 8185285.
DOI: 10.3389/fncel.2021.644507.
The neural economics of brain aging.
Kosyakovsky J
Sci Rep. 2021; 11(1):12167.
PMID: 34108560
PMC: 8190309.
DOI: 10.1038/s41598-021-91621-5.
USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Li Y, Zhou J
Cancer Manag Res. 2021; 13:3913-3924.
PMID: 34012297
PMC: 8128349.
DOI: 10.2147/CMAR.S290467.
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders.
Devi S, Kumar V, Singh S, Dubey A, Kim J
Biomedicines. 2021; 9(2).
PMID: 33498503
PMC: 7909525.
DOI: 10.3390/biomedicines9020099.